Publishing research using ab45145? Please let us know so that we can cite the reference in this datasheet.

ab45145 has been referenced in 17 publications.

  • Xie CM  et al. Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway. Oncotarget 9:13783-13795 (2018). PubMed: 29568394
  • Lin J  et al. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells. Cancer Sci 109:1001-1011 (2018). WB ; Human . PubMed: 29427543
  • Li R  et al. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins. J Biol Chem 292:2830-2841 (2017). PubMed: 28073914
  • Fischer MM  et al. WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death. Sci Adv 3:e1700090 (2017). PubMed: 28691093
  • Henssen AG  et al. Targeting tachykinin receptors in neuroblastoma. Oncotarget 8:430-443 (2017). WB ; Human . PubMed: 27888795
  • Zhang X  et al. Mps1 kinase regulates tumor cell viability via its novel role in mitochondria. Cell Death Dis 7:e2292 (2016). WB, ICC/IF . PubMed: 27383047
  • Ye L  et al. Cardiomyocytes in Young Infants With Congenital Heart Disease: a Three-Month Window of Proliferation. Sci Rep 6:23188 (2016). IF . PubMed: 26976548
  • Sakai S  et al. In vitro evaluation of a combination treatment involving anticancer agents and an aurora kinase B inhibitor. Oncol Lett 12:4263-4269 (2016). PubMed: 27895801
  • Yu JJ  et al. Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells. Oncol Lett 10:1642-1648 (2015). PubMed: 26622725
  • Kawai M  et al. Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family. J Biomed Sci 22:48 (2015). PubMed: 26141684
  • Chuang MJ  et al. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. PLoS One 8:e73401 (2013). WB ; Human . PubMed: 24023871
  • Failes TW  et al. Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells. PLoS One 7:e30734 (2012). WB, ICC/IF ; Human . PubMed: 22359551
  • Fraedrich K  et al. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model. Clin Cancer Res 18:4621-32 (2012). Human . PubMed: 22753592
  • Fichter CD  et al. Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells. BMC Cell Biol 12:13 (2011). WB . PubMed: 21470402
  • Shah OJ  et al. Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization. Proc Natl Acad Sci U S A 107:12634-9 (2010). PubMed: 20616035
  • Ikezoe T  et al. Analysis of Aurora B kinase in non-Hodgkin lymphoma. Lab Invest 89:1364-73 (2009). PubMed: 19823168
  • Fiskus W  et al. Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells. Clin Cancer Res 14:6106-15 (2008). PubMed: 18829489

For licensing inquiries, please contact

Sign up